» Articles » PMID: 36294611

The Human Mycobiome: Colonization, Composition and the Role in Health and Disease

Overview
Journal J Fungi (Basel)
Date 2022 Oct 27
PMID 36294611
Authors
Affiliations
Soon will be listed here.
Abstract

The mycobiome is the fungal component of the human microbial ecosystem that represents only a small part of this environment but plays an essential role in maintaining homeostasis. Colonization by fungi begins immediately after birth. The initial mycobiome is influenced by the gestational age of a newborn, birth weight, delivery method and feeding method. During a human's life, the composition of the mycobiome is further influenced by a large number of endogenous and exogenous factors. The most important factors are diet, body weight, age, sex and antibiotic and antifungal therapy. The human mycobiome inhabits the oral cavity, gastrointestinal tract, respiratory tract, urogenital tract and skin. Its composition can influence the gut-brain axis through immune and non-immune mediated crosstalk systems. It also interacts with other commensals of the ecosystem through synergistic and antagonistic relationships. Moreover, colonization of the gut by opportunistic fungal pathogens in immunocompromised individuals can lead to clinically relevant disease states. Thus, the mycobiome represents an essential part of the microbiome associated with a variety of physiological and pathological processes. This review summarizes the current knowledge on the composition of the mycobiome in specific sites of the human body and its role in health and disease.

Citing Articles

Impact of Saharan Dust and Gene Variants on Bacterial/Fungal Balance in Asthma Patients.

Escuela-Escobar A, Perez-Garcia J, Martin-Gonzalez E, Gonzalez Martin C, Hernandez-Perez J, Gonzalez Perez R Int J Mol Sci. 2025; 26(5).

PMID: 40076778 PMC: 11899813. DOI: 10.3390/ijms26052158.


A mass spectrometry-based strategy for investigating volatile molecular interactions in microbial consortia: unveiling a -specific induction of an antifungal compound.

Azzollini A, Sgorbini B, Lecoultre N, Bicchi C, Wolfender J, Rubiolo P Front Microbiol. 2025; 15:1417919.

PMID: 40070966 PMC: 11895703. DOI: 10.3389/fmicb.2024.1417919.


The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target.

Parodi E, Novi M, Bottino P, La Porta E, Merlotti G, Castello L Microorganisms. 2025; 13(2).

PMID: 40005809 PMC: 11858628. DOI: 10.3390/microorganisms13020445.


Brain Tumors and Beyond: Multi-Compartment Microbiome and Mycobiome Analysis.

Sipos L, Banczerowski P, Juhasz J, Fedorcsak I, Berenyi G, Makra N Int J Mol Sci. 2025; 26(3).

PMID: 39940760 PMC: 11817552. DOI: 10.3390/ijms26030991.


The Acari Hypothesis, V: deciphering allergenicity.

Retzinger A, Retzinger G Front Allergy. 2024; 5:1454292.

PMID: 39552700 PMC: 11565521. DOI: 10.3389/falgy.2024.1454292.


References
1.
Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C . Fungal microbiota dysbiosis in IBD. Gut. 2016; 66(6):1039-1048. PMC: 5532459. DOI: 10.1136/gutjnl-2015-310746. View

2.
Huseyin C, Rubio R, OSullivan O, Cotter P, Scanlan P . The Fungal Frontier: A Comparative Analysis of Methods Used in the Study of the Human Gut Mycobiome. Front Microbiol. 2017; 8:1432. PMC: 5534473. DOI: 10.3389/fmicb.2017.01432. View

3.
Bradford L, Ravel J . The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases. Virulence. 2016; 8(3):342-351. PMC: 5411243. DOI: 10.1080/21505594.2016.1237332. View

4.
Nagata R, Nagano H, Ogishima D, Nakamura Y, Hiruma M, Sugita T . Transmission of the major skin microbiota, Malassezia, from mother to neonate. Pediatr Int. 2012; 54(3):350-5. DOI: 10.1111/j.1442-200X.2012.03563.x. View

5.
Nash A, Auchtung T, Wong M, Smith D, Gesell J, Ross M . The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 2017; 5(1):153. PMC: 5702186. DOI: 10.1186/s40168-017-0373-4. View